These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19527473)

  • 1. Plasma concentration of pioglitazone in patients with type 2 diabetes on hemodialysis.
    Abe M; Kikuchi F; Okada K; Matsumoto K
    Ther Apher Dial; 2009 Jun; 13(3):238-9. PubMed ID: 19527473
    [No Abstract]   [Full Text] [Related]  

  • 2. Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.
    Christensen ML; Meibohm B; Capparelli EV; Velasquez-Mieyer P; Burghen GA; Tamborlane WV
    J Clin Pharmacol; 2005 Oct; 45(10):1137-44. PubMed ID: 16172178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

  • 4. Pioglitazone/glimepiride (Duetact) for diabetes.
    Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study.
    Vlckova V; Cornelius V; Kasliwal R; Wilton L; Shakir S
    J Eval Clin Pract; 2010 Dec; 16(6):1124-8. PubMed ID: 21176002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we now ADOPT glitazones earlier in treatment of type 2 diabetes?
    Howat I; Cleland SJ
    Int J Clin Pract; 2007 Jul; 61(7):1071-3. PubMed ID: 17577291
    [No Abstract]   [Full Text] [Related]  

  • 7. Coadministration of pioglitazone or glyburide and alogliptin: pharmacokinetic drug interaction assessment in healthy participants.
    Karim A; Laurent A; Munsaka M; Wann E; Fleck P; Mekki Q
    J Clin Pharmacol; 2009 Oct; 49(10):1210-9. PubMed ID: 19622714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review].
    Madsbad S
    Ugeskr Laeger; 2007 Nov; 169(47):4054-7. PubMed ID: 18078659
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetes manifestation. Should they be prevented with drugs?].
    MMW Fortschr Med; 2006 Oct; 148(41):12, 15. PubMed ID: 17190250
    [No Abstract]   [Full Text] [Related]  

  • 10. [Wrong choice of antidiabetics can be disastrous].
    Sjöholm A
    Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2300-1. PubMed ID: 20973243
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone and bladder cancer: the pros and cons.
    Panikar V
    J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus.
    Harashima K; Hayashi J; Miwa T; Tsunoda T
    Metabolism; 2009 Jun; 58(6):739-45. PubMed ID: 19446110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value equation for rosiglitazone and pioglitazone in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients.
    Aramwit P; Supasyndh O; Sriboonruang T
    J Clin Pharm Ther; 2008 Dec; 33(6):685-90. PubMed ID: 19138247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones and the renal and hormonal response to water immersion-induced volume expansion in type 2 diabetes mellitus.
    Goenka N; Kotonya C; Penney MD; Randeva HS; O'Hare JP
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E733-9. PubMed ID: 18230694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone safe, so save.
    Banerjee S
    J Assoc Physicians India; 2012 Jan; 60():62-6. PubMed ID: 22715548
    [No Abstract]   [Full Text] [Related]  

  • 18. Massive bilateral pleural effusion associated with use of pioglitazone.
    Chen YW; Chen YC; Wu CJ; Chen HH
    Clin Ther; 2008 Aug; 30(8):1485-9. PubMed ID: 18803990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REVISITING THE USE OF PIOGLITAZONE IN THE TREATMENT OF TYPE 2 DIABETES.
    Einhorn D; Fonseca V
    Endocr Pract; 2016 Nov; 22(11):1343-1346. PubMed ID: 27540881
    [No Abstract]   [Full Text] [Related]  

  • 20. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
    Lehmann DF; Lohray BB
    J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.